Liminatus Pharma, Inc. (LIMN)

Liminatus Pharma, Inc., a pre-clinical stage biopharmaceutical company, engages in the development of cancer therapies in the United States. It develops IBA101, a humanized anti CD47 monoclonal antibody, which is in Phase I clinical trial for the treatment of advanced solid cancers, including non-small cell lung cancer. The company was founded in 2018 and is based in Cerritos, California.

Ticker
LIMN
Exchange
Nasdaq
Sector
Healthcare
Industry
Biotechnology
Market cap
$3.03M
52-week range
$2.40 - $141.50

Valuation

Share price
$2.68 (close of Nov 18, 2026)
P/E (TTM)
-0.13x
Price to book
10.09x
Price to free cash flow
-0.76x
Enterprise value
$4.48M
Book value per share
$0.27

Price performance

PeriodChange
1 day-4.63%
5 days-8.84%
1 month-11.84%
3 months-58.77%
6 months-71.34%
Year to date-91.21%
1 year-95.17%
All time-99.33%

Short interest

As of
Oct 30, 2026
Short % of float
4.43%
Shares short
47.91K
Days to cover
1.65
Change since prior report
+20.89%
Source
FINRA consolidated short interest

Profitability and growth

Return on capital employed
30.33%

Cash flow and balance sheet

Free cash flow yield (TTM)
-131.39%
Current ratio
1.12x
Net debt to EBITDA
-0.12x

Latest reported year

Period end
Dec 31, 2025
Fiscal year
2025
EBITDA
-$2.97M
Net income
-$10.21M
Interest expense
$215.90K

Income statement by year

Period endNet income
2025-12-31-$10.21M
2024-12-31-$3.55M

Free cash flow by year

Period endFree cash flow
2025-12-31-$9.98M
2024-12-31-$1.45M

Investor relations

Next earnings report

Next confirmed report
Nov 19, 2026

Past earnings dates

ReportedFiscal periodEPS estimate
2026-11-12Sep 2026-
2026-08-14Jun 2026-
2026-05-15Mar 2026-
2026-03-31Dec 2025-
2025-11-13Sep 2025-
2025-10-03Jun 2025-

Filings and sources

Company website
liminatuspharma.com
SEC filings
10-K, 10-Q and 8-K on EDGAR
Earnings calendar
All upcoming reports

Similar companies

Vertex Pharmaceuticals Inc (VRTX) · Regeneron Pharmaceuticals, Inc. (REGN) · Moderna, Inc. (MRNA) · Incyte Corp (INCY) · Insmed Inc (INSM) · Bio-Techne Corp (TECH) · Thermo Fisher Scientific Inc. (TMO) · Danaher Corp (DHR)

All Healthcare companies

Understanding these figures

Price-to-earnings ratio · Short interest · Discounted cash flow · Free cash flow · Earnings per share · Return on equity · Gross margin vs net margin · Reading a balance sheet · Debt and leverage · Dividend yield · Insider transactions and Form 4 · How to read a stock chart

Explore

Company directory · S&P 500 heatmap · Earnings calendar · Super investor holdings · Congress trades